Home News Brazil Reduces Use of China’s New Coronavirus Vaccine-Wall Street Journal

Brazil Reduces Use of China’s New Coronavirus Vaccine-Wall Street Journal

by admin

Brazil is the main buyer of China‘s new crown vaccine, CoronaVac, and a typical representative of the achievements of the Chinese government’s vaccine diplomacy. But as people’s concerns about the vaccine’s effectiveness against delta mutant strains intensify, and other vaccines become more accessible, Brazil is rapidly abandoning the new crown vaccine.

A spokesperson for the Brazilian government and the Butantan Institute, the local manufacturer of the vaccine, told The Wall Street Journal that the Brazilian federal government has suspended further purchases of Sinovac Biotech Ltd. (SVA). Negotiations on the vaccine Kerlaifu. The Brazilian government also stated that it does not recommend the use of Kellyford as the third booster shot.

As Brazil changes its attitude towards Chinese vaccines, several other Latin American countries and some Southeast Asian countries have also reduced their dependence on China-made new crown vaccines. This signifies that as the United States has established itself as the preferred global supplier, countries are responding to the new crown epidemic. There may be a turning point in its efforts. Brazil relied heavily on vaccines made in China earlier this year.


See also  Know | 8~22℃, major progress! China Biotech's second-generation recombinant protein new crown vaccine was approved for clinical use! Daxing District received a report of a positive nucleic acid, and the main activity track was announced! - Sina

You may also like

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy